(NYSE:ELV), NEW YORK, July 02, 2025 (GLOBE NEWSWIRE) — WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of common stock of Elevance Health, Inc. (NYSE: ELV) between April 18, 2024 and October 16, 2024, both dates inclusive (the “Class Period”), of the important July 11, 2025 lead plaintiff deadline. SO WHAT: […]

ELV DEADLINE: ROSEN, A RANKED AND LEADING LAW FIRM, Encourages Elevance Health, Inc. Investors with Losses in Excess of $100K to Secure Counsel Before Important July 11 Deadline in Securities Class Action – ELV GlobeNewswire July 02, 2025 NEW YORK, July 02, 2025 (GLOBE NEWSWIRE) — WHY: Rosen Law Firm, a global investor rights law

— The U.S. softwood lumber industry is a critical manufacturing industry essential to the national economic strength and the industrial resilience of the United States — Canada's unfair trade in softwood lumber continues to be extremely harmful to U.S. producers and workers — Strong trade law enforcement is paramount to bringing about fair pricing of

In the news release, Appian Strengthens Leadership Team with Key Hires in UK and EMEA, issued 02-Jul-2025 by Appian over PR Newswire, we are advised by the company that the name “Vicky Nesbit” should read “Vicky Nisbet”. The complete, corrected release follows: Appian Strengthens Leadership Team with Key Hires in UK and EMEA Enterprise Software

(NASDAQ:DNUT), LOS ANGELES, July 02, 2025 (GLOBE NEWSWIRE) — Glancy Prongay & Murray LLP reminds investors of the upcoming July 15, 2025 deadline to file a lead plaintiff motion in the class action filed on behalf of investors who purchased or otherwise acquired Krispy Kreme, Inc. (“Krispy Kreme” or the “Company”) (NASDAQ: DNUT) securities between

Deadline Alert: Krispy Kreme, Inc. (DNUT) Investors Who Lost Money Urged To Contact Glancy Prongay & Murray LLP About Securities Fraud Lawsuit GlobeNewswire July 02, 2025 LOS ANGELES, July 02, 2025 (GLOBE NEWSWIRE) — Glancy Prongay & Murray LLP reminds investors of the upcoming July 15, 2025 deadline to file a lead plaintiff motion in

Camden National Corporation (NASDAQ: CAC) will report financial and operating results for the quarter ended June 30, 2025 on Tuesday, July 29, 2025.A conference call and webcast will be held at 3:00 p.m. Eastern on Tuesday, July 29, 2025, and hosted by Simon Griffiths, President and Chief Executive Officer, Michael Archer, Executive Vice President, Chief

Emerging Clinical Trial Infrastructure in the MENA Region: A Comprehensive Market Analysis “Insights into MENA's Clinical Trial Markets: Providing a Focused Analysis of Emerging Opportunities, Challenges, and Market Dynamics from 2024 to 2029” GlobeNewswire July 02, 2025 Boston, July 02, 2025 (GLOBE NEWSWIRE) — According to the latest study from BCC Research, “Clinical Trial Infrastructure

(NasdaqGM:VEON), Dubai, July 2, 2025: VEON Ltd. (Nasdaq: VEON), a global digital operator (“VEON”), announces today that it has completed the pricing of a private placement of USD 200 million of senior unsecured notes due in 2029 with institutional investors (the “Notes”), following its announcement on June 16, 2025 that it is considering options to

VEON Raises USD 200 Million in Private Bond Placement GlobeNewswire July 02, 2025 Dubai, July 2, 2025: VEON Ltd. (Nasdaq: VEON), a global digital operator (“VEON”), announces today that it has completed the pricing of a private placement of USD 200 million of senior unsecured notes due in 2029 with institutional investors (the “Notes”), following